Bleeding and venous thromboembolism in the critically ill with emphasis on patients with renal insufficiency

被引:8
作者
Cook, Deborah J. [1 ,2 ]
Douketis, James [2 ]
Arnold, Donald
Crowther, Mark A.
机构
[1] McMaster Univ, Dept Med, Hlth Sci Ctr, Hamilton, ON L8N 3Z5, Canada
[2] McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON L8N 3Z5, Canada
关键词
prevention; renal failure; venous thromboembolism; DEEP-VEIN THROMBOSIS; MOLECULAR-WEIGHT HEPARINS; ACUTE CORONARY SYNDROMES; ARTERY-BYPASS-SURGERY; DIALYSIS PATIENTS; INTENSIVE-CARE; RISK-FACTORS; PREVENTION; SAFETY; DALTEPARIN;
D O I
10.1097/MCP.0b013e32832ea4dd
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Purpose of review The purpose of this review is to critique and summarize clinical literature relevant to thromboprophylaxis in critically ill patients with renal insufficiency. The specific objectives are to discuss factors that increase the risks for bleeding and venous thromboembolism in critically ill patients, with a focus on patients with renal insufficiency, and to consider prophylaxis management options and the rationale for their use. Recent findings Herein, we discuss both bleeding and venous thromboembolism in this population, both of which are of concern as complications. Bleeding is common among critically ill patients and has important clinical consequences. Critically ill patients with renal insufficiency require special consideration in regard to thromboprophylaxis. Such patients have a four-fold higher risk for developing venous thromboembolism compared with ICU patients without renal insufficiency. ICU patients have dynamic risks of thrombosis and bleeding. Invasive procedures may require temporary interruption of anticoagulants. Consequently, approaches to thromboprophylaxis require daily reevaluation. Summary We provide some considerations for practice in the conclusion section.
引用
收藏
页码:455 / 462
页数:8
相关论文
共 39 条
  • [1] Renal failure predisposes patients to adverse outcome after coronary artery bypass surgery
    Anderson, RJ
    O'Brien, M
    MaWhinney, S
    VillaNueva, CB
    Moritz, TE
    Sethi, GK
    Henderson, WG
    Hammermeister, KE
    Grover, FL
    Shroyer, AL
    [J]. KIDNEY INTERNATIONAL, 1999, 55 (03) : 1057 - 1062
  • [2] Arnold DM, 2007, CLIN INVEST MED, V30, pE93
  • [3] Deep vein thrombosis and its prevention in critically ill adults
    Attia, J
    Ray, JG
    Cook, DJ
    Douketis, J
    Ginsberg, JS
    Geerts, WH
    [J]. ARCHIVES OF INTERNAL MEDICINE, 2001, 161 (10) : 1268 - 1279
  • [4] Efficacy and safety of recombinant human activated protein C for severe sepsis.
    Bernard, GR
    Vincent, JL
    Laterre, P
    LaRosa, SP
    Dhainaut, JF
    Lopez-Rodriguez, A
    Steingrub, JS
    Garber, GE
    Helterbrand, JD
    Ely, EW
    Fisher, CJ
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (10) : 699 - 709
  • [5] A comparison of sucralfate and ranitidine for the prevention of upper gastrointestinal bleeding in patients requiring mechanical ventilation
    Cook, D
    Guyatt, G
    Marshall, J
    Leasa, D
    Fuller, H
    Hall, R
    Peters, S
    Rutledge, F
    Griffith, L
    McLellan, A
    Wood, G
    Kirby, A
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1998, 338 (12) : 791 - 797
  • [6] Deep venous thrombosis in medical-surgical critically ill patients: Prevalence, incidence, and risk factors
    Cook, D
    Crowther, M
    Meade, M
    Rabbat, C
    Griffith, L
    Schiff, D
    Geerts, W
    Guyatt, G
    [J]. CRITICAL CARE MEDICINE, 2005, 33 (07) : 1565 - 1571
  • [7] Prophylaxis of Thromboembolism in Critical Care (PROTECT)Trial:: a pilot study
    Cook, DJ
    Rocker, G
    Meade, M
    Guyatt, G
    Geerts, W
    Anderson, D
    Skrobik, Y
    Hebert, P
    Albert, M
    Cooper, J
    Bates, S
    Caco, C
    Finfer, S
    Fowler, R
    Freitag, A
    Granton, J
    Jones, G
    Langevin, S
    Mehta, S
    Pagliarello, G
    Poirier, G
    Rabbat, C
    Schiff, D
    Griffith, L
    Crowther, M
    [J]. JOURNAL OF CRITICAL CARE, 2005, 20 (04) : 364 - 372
  • [8] COOK DJ, 2003, CRIT CARE S2, V20, P309
  • [9] Cooke FJ, 2008, INT J INFECT DIS, V12, P1
  • [10] Efficacy and safety of epoetin alfa in critically ill patients
    Corwin, Howard L.
    Gettinger, Andrew
    Fabian, Timothy C.
    May, Addison
    Pearl, Ronald G.
    Heard, Stephen
    An, Robert
    Bowers, Peter J.
    Burton, Paul
    Klausner, Mark A.
    Corwin, Michael J.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2007, 357 (10) : 965 - 976